UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): March 15, 2017

                                 AMERICANN, INC.
                       -----------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                     000-54231                 27-4336843
  --------------------------        -----------------         ----------------
 (State or other jurisdiction     (Commission File No.)     (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                    ---------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000


          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement  communications  pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

                                       1
<PAGE>

 Item 8.01. Other Events

     On March 23, 2017, AmeriCann,  Inc.'s CEO, Tim Keogh, will be a panelist at
a summit organized by Jeffries,  LLC, a Global  Investment  Banking Firm, in San
Francisco,   CA.  The  private  event  will  consist  of  1-on-1  meetings  with
institutional  investors and an expert panel  presentation by leading public and
private companies operating in the emerging cannabis industry.

     On March 17, 2017,  AmeriCann  retained  the  services of a  Maryland-based
government  affairs firm to assist in identifying  opportunities  and monitoring
legislative and regulatory changes in Maryland's medical marijuana market.

Item 1.01.  Entry Into a Material Definitive Agreement

     On July 31, 2014,  AmeriCann  closed on an all cash purchase of a five-acre
parcel of land located in Denver,  Colorado.  The total  purchase  price for the
property  was   $2,250,000.   The  property  is  currently  zoned  for  cannabis
cultivation  and  processing  by the City and  County  of Denver  and  serves as
collateral for a $990,000 loan which was payable on March 15, 2017. On March 15,
2017 the maturity date of the loan was extended to March 15, 2018.  The interest
rate on the loan, 18% per year, remained the same.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: March 20, 2017
                                      AMERICANN, INC.


                                      By:  Timothy Keogh
                                           -------------------------------
                                          Timothy Keogh, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101extdloan3-17.txt", "description": "8-K ITEM 1.01", "secsgml_size_bytes": 3756}]
{"company-data": {"conformed-name": "AmeriCann, Inc.", "cik": "0001508348", "assigned-sic": "8742", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "17702554"}, "business-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216", "phone": "303-898-9832"}, "mail-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216"}, "former-company": [{"former-conformed-name": "Americann, Inc.", "date-changed": "20140516"}, {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): March 15, 2017

                                 AMERICANN, INC.
                       -----------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                     000-54231                 27-4336843
  --------------------------        -----------------         ----------------
 (State or other jurisdiction     (Commission File No.)     (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                    ---------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement  communications  pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

                                       1
Item 8.01. Other Events

     On March 23, 2017, AmeriCann,  Inc.'s CEO, Tim Keogh, will be a panelist at
a summit organized by Jeffries,  LLC, a Global  Investment  Banking Firm, in San
Francisco,   CA.  The  private  event  will  consist  of  1-on-1  meetings  with
institutional  investors and an expert panel  presentation by leading public and
private companies operating in the emerging cannabis industry.

     On March 17, 2017,  AmeriCann  retained  the  services of a  Maryland-based
government  affairs firm to assist in identifying  opportunities  and monitoring
legislative and regulatory changes in Maryland's medical marijuana market.

Item 1.01.  Entry Into a Material Definitive Agreement

     On July 31, 2014,  AmeriCann  closed on an all cash purchase of a five-acre
parcel of land located in Denver,  Colorado.  The total  purchase  price for the
property  was   $2,250,000.   The  property  is  currently  zoned  for  cannabis
cultivation  and  processing  by the City and  County  of Denver  and  serves as
collateral for a $990,000 loan which was payable on March 15, 2017. On March 15,
2017 the maturity date of the loan was extended to March 15, 2018.  The interest
rate on the loan, 18% per year, remained the same.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: March 20, 2017
                                      AMERICANN, INC.

                                      By:  Timothy Keogh
                                           -------------------------------
                                          Timothy Keogh, Chief Executive Officer